Edward Paul
Optometrist · Wilmington, NCNPI 1043377948
Payments from drug & device makers
Across 36 payments — averaging $102.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Notal Vision, Inc.$2K
- Alcon$643
- Biotissue Holdings Inc.$232
- Coopervision Inc.$195
- Bausch & Lomb, A Division Of Bausch Health US, LLC$170
- NEW World Medical,inc.$124
- plus $163 from 7 others
What the payments were for
- Speaking & faculty fees$1,98256%
- Food & beverage$1,52744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Notal Vision, Inc. | 10 | $2,162 |
| Alcon | 10 | $643 |
| Biotissue Holdings Inc. | 2 | $232 |
| Coopervision Inc. | 2 | $195 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $170 |
| NEW World Medical,inc. | 1 | $124 |
| Oyster Point Pharma, Inc. | 2 | $47 |
| Novartis | 1 | $25 |
| Thea Pharma Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 2 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Amgen | 1 | $16 |
| Spark Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Foresee Home$1,500
- Precision7$113
- Precision 1$108
- MyDay Contact Lens$103
- TOTAL30$101
How this compares
$3,689 in reported general payments places this provider in the 80th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 21 | $16,826 |
| Cyclosporine | 11 | $4,080 |
| VyzultaLatanoprostene Bunod | 11 | $2,653 |
| Latanoprost | 96 | $816 |
| Brimonidine Tartrate | 11 | $661 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $273 |
| Timolol Maleate | 25 | $241 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Wilmington
- Crystal BrimerWilmington$920K
- James FanelliWilmington$67K
- Rasika WhitesellWilmington$40K
- Tracey GlendenningWilmington$13K
- Chris GlendenningWilmington$11K
- Jason HendrixWilmington$11K
- Michael SchilawskiWilmington$11K
- Hilary CoxWilmington$9K
- Carol AuneRaleigh$1.7M
- Osama SaidRaleigh$597K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.